metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Linfadenectomía selectiva (ganglio centinela) en el melanoma. Experiencia con 5...
Información de la revista
Vol. 69. Núm. 2.
Páginas 99-102 (febrero 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 69. Núm. 2.
Páginas 99-102 (febrero 2001)
Acceso a texto completo
Linfadenectomía selectiva (ganglio centinela) en el melanoma. Experiencia con 55 casos
Selective lymphadenectomy (Sentinel node) in melanoma. A study of 55 cases
Visitas
7113
M.J. Giménez*,1, M.V. Fliquete***, C.A. Fuster*, C. Vázquez Forner**, F. Llopis*, J.L. Arnal**, I. Bolumar**, R. Botella*, C. Guillem***, S. Almenar****, C. Vázquez Albaladejo*****
* Servicios de Cirugía
** Servicios de Medicina Nuclear
*** Servicios de Dermatología
**** Servicios de Anatomía Patológica
***** Jefe de Servicio de Cirugía. Instituto Valenciano de Oncología. Valencia.
Este artículo ha recibido
Información del artículo
Resumen
Introducción

El ganglio centinela (NC) es la primera estación de drenaje linfático de una lesión primitiva y, por tanto, con la máxima probabilidad de albergar una metástasis.

El objetivo de este trabajo es ahorrar la morbilidad y coste de linfadenectomías innecesarias en pacientes con melanoma clínicamente no diseminado (75-89%) y mejorar la estadificación por localización del NC fuera del área de drenaje habitual.

Pacientes y métodos

Se han estudiado 55 pacientes con diagnóstico de melanoma de riesgo intermedio (Breslow 0,75-4 mm).

Para localizar las áreas de drenaje linfático, a todos los pacientes se les realizó una linfogammagrafía mediante la inyección intradérmica subcicatrizal de sulfuro coloidal-99mTc antes de la intervención. Veinte minutos antes de ésta se inyectó igualmente 1 cm3 de azul de isosulfán (Lymphazurin®).

La búsqueda intraoperatoria del NC se realizó en 9 pacientes con el colorante exclusivamente y en 46 con la técnica combinada del colorante y una sonda detectora de rayos gamma (Navigator®).

Resultados

El NC se localizó en 53 pacientes (96%), estaba infiltrado en siete de ellos (13%) y era el único ganglio afectado en cinco (71,5%).

Conclusiones

La linfadenectomía selectiva en el melanoma es una técnica de escasa morbilidad, que puede evitar linfadenectomías completas innecesarias en pacientes con melanoma de riesgo intermedio.

Palabras clave:
Ganglio centinela
Melanoma
Linfadenectomía
Introduction

Sentinel nodes (SN) are those most likely to receive lymphatic drainage from a primary tumor, and therefore to develop metastases. The objective of the present study was to avoid the morbidity and costs associated with unnecessary lymphadenectomies in patients with clinically non-disseminated melanoma (75-89%), and to improve staging, by localization of the sentinel node outside the normal drainage area.

Patients and methods

55 patients diagnosed with melanoma of intermediate risk (Breslow 0.75-4 mm) were studied.

In order to identify areas of lymphatic drainage, all patients underwent preoperative lymphoscintigraphy with sulfur colloid 99mTc injected intradermally around the biopsy scar.

Patients had been injected 20 minutes earlier with 1 cc of Isosulfan Blue (Lymphazurin®). Intraoperative mapping of SN was performed using dye only in 9 patients and using a combination of dye and a gamma probe (Navigator®) in the remaining 46 patients.

Results

The sentinel node was identified in 53 patients (96%), and was positive in 7 of these cases (13%). It was the only lymph node affected in 5 of these cases (71.5%).

Conclusions

Selective lymphadenectomy in melanoma is a low-morbidity technique which makes it possible to avoid unnecessary lymphadenectomy in patients with intermediate risk melanoma.

Key words:
Sentinel ganglion
Melanoma
Lymphadenectomy
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.M. Cabañas.
An approach for the treatment of penile carcinoma.
Cancer, 39 (1977), pp. 456-466
[2.]
H.J. Gray.
Relation of the lymphatic vessels to the spread of cancer.
Br J Surg, 26 (1936), pp. 462-495
[3.]
K.R. Cox, W.S. Hare, P.T. Bruce.
Lymphography in melanoma. Correlation of radiology with pathology.
Cancer, 19 (1966), pp. 637-647
[4.]
J.H. Wong, L.A. Cagle, D.L. Morton.
Lymphatic drainage of skin to a sentinel lymphnode in a feline model.
Ann Surg, 214 (1991), pp. 637-641
[5.]
D. Reitgen, C.W. Cruse, K. Welks, C. Berman, N. Frenske, F. Glass, et al.
The orderly progression of melanoma nodal metastases.
Ann Surg, 220 (1994), pp. 759-767
[6.]
D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, F.K. Storm, et al.
Technical details of intraoperative lymphatic mapping for early stage melanoma.
Arch Surg, 127 (1992), pp. 392-399
[7.]
D.L. Morton, D.R. Wen, A.J. Cochran.
Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy.
Surg Oncol Clin North Am, 1 (1992), pp. 247-259
[8.]
J.F. Thompson, W.H. McCarthy, C.M. Bosch.
Sentinel lymph node status as an indicator of the presence of melanoma in the regional lymph nodes.
Melanoma Res, 5 (1995), pp. 255-260
[9.]
J.J. Albertinini, C.W. Cruse, D. Rappaport.
Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma.
Ann Surg, 2 (1996), pp. 217-224
[10.]
D.N. Krag, S.J. Meijer, D.L. Weaver.
Minimal-access surgery for staging of malignant melanoma.
Arch Surg, 130 (1995), pp. 654-658
[11.]
J.C. Alex, D.N. Krag.
Gamma-probe-guided localization of lymph nodes.
Surg Oncol, 2 (1993), pp. 137-144
[12.]
A.E. Giuliano, D.M. Kirgan, J.M. Guenther, D.L. Morton.
Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
Ann Surg, 220 (1994), pp. 391-401
[13.]
Bostick P, Essner R, Glass E. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins [resumen]. Society of Surgical Oncology 50th Annual Cancer Symposium. Chicago, 20-23 de marzo de 1997.
[14.]
N. Cascinelli, A. Morabito, M. Santinami, R.M. Mackie, F. Belli, on behalf of the WHO Melanoma Programme..
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial.
Lancet, 351 (1998), pp. 793-796
[15.]
C.M. Balch, S.J. Soong, A.A. Bartolucci.
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
Ann Surg, 224 (1996), pp. 255-266
[16.]
U. Veronesi, J. Adamus, D.C. Bandiera.
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.
Cancer, 49 (1982), pp. 2420-2430
[17.]
F.H. Sim, W.F. Taylor, D.J. Pritchard, E.H. Soule.
Limphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.
Mayo Clin Proc, 61 (1986), pp. 697-705
[18.]
M.I. Ross.
Surgical management of stage I and II melanoma patients approach to the regional lymph node basin.
[19.]
L. Lee, Q. Pu, C.W. Cruse, K.E. Wells, A. Cantor, L.F. Glass, et al.
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity Plast.
Reconstr Surg, 104 (1999), pp. 964-969
[20.]
E.M. Ramnath, D. Kamath, A. Brobeil.
Limphatyc mapping for melanoma: long term results of regional nodal sampling with radioguided surgery.
Cancer Control, 4 (1997), pp. 483
[21.]
S.P.L. Leong, I. Steinmetz, F.A. Habib, A. McMillan, J.Z. Gans, R.E. Allen, et al.
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
Arch Surg Oncol, 132 (1998), pp. 666
[22.]
M.C. Kelley, D.W. Ollilla, D.L. Morton.
Lymphatic mapping and sentinel lymphadenectomy for melanoma.
Semin Surg Oncol, 14 (1998), pp. 283
[23.]
J.E. Gershenwald, M.I. Colome, J.E. Lee.
Paterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
J Clin Oncol, 6 (1998), pp. 2253
[24.]
T. Cottingham, J. Larson, J.P. Delaney, C. Zachary.
Sentinel node dissection in the tratment of melanoma: report of three cases and rewiew of the literature.
Dermatol Surg, 23 (1997), pp. 113-119
[25.]
D.N. Krag, S.J. Meijer, D.L. Weaver, B.W. Loggie, S.P. Harlow, K.K. Tanabe, et al.
Minimal acces surgery for staging of malignant melanoma.
Arch Surg, 130 (1995), pp. 654-658
[26.]
E. Joseph, J. Messina, F.L. Glass, C.W. Cruse, D.P. Rapaport, C. Berman, et al.
Radioguided surgery for the ultrastaging of the patient with melanoma.
Cancer J Sci Am, 3 (1997), pp. 341-345
[27.]
R. Gennari, M. Bartolomei, S. Zurrida, H.S. Stoldt, R.A. Audisio, J.G. Geraghty, et al.
Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe and vital dye guidance.
Surgery, 126 (1999), pp. 19-25
[28.]
P. Walsh, P. Gibbs, R. González.
Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease.
J Am Acad Dermatol, 42 (2000), pp. 480-489
[29.]
L.L. Yu, T.J. Flotte, K.K. Tanabe, M.A. Gadd, A.B. Cosimi, A.J. Sober, et al.
Detection of microscopic melanoma metastases in sentinel lymph nodes.
Cancer, 86 (1999), pp. 617-627
[30.]
P. Rosen, P. Saigo, D. Braun, E. Weathers, A. Fracchia, D. Kinne.
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size.
Ann Surg, 194 (1981), pp. 585-591
[31.]
A. Huvos, R. Hutter, J. Berg.
Significance of axillary macrometastases and micrometastases in mammary cancer.
Ann Surg, 173 (1971), pp. 44-46
Copyright © 2001. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos